Jailendra Singh
Stock Analyst at Truist Securities
(0.82)
# 3,696
Out of 4,734 analysts
167
Total ratings
24.18%
Success rate
-25.1%
Average return
Main Sectors:
Stocks Rated by Jailendra Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VEEV Veeva Systems | Maintains: Hold | $261 → $210 | $223.04 | -5.85% | 7 | Jan 13, 2025 | |
| EVH Evolent Health | Maintains: Buy | $24 → $20 | $10.17 | +96.66% | 3 | Jan 13, 2025 | |
| ASTH Astrana Health | Maintains: Buy | $59 → $50 | $37.14 | +34.63% | 4 | Jan 13, 2025 | |
| ICLR ICON Public Limited Company | Reiterates: Buy | $295 → $284 | $205.07 | +38.49% | 7 | Dec 18, 2024 | |
| IQV IQVIA Holdings | Maintains: Buy | $265 → $261 | $205.69 | +26.89% | 13 | Dec 12, 2024 | |
| PHR Phreesia | Maintains: Buy | $31 → $34 | $27.35 | +24.31% | 5 | Dec 11, 2024 | |
| DOCS Doximity | Maintains: Hold | $35 → $49 | $55.52 | -11.74% | 6 | Nov 14, 2024 | |
| PGNY Progyny | Downgrades: Hold | $26 → $19 | $21.48 | -11.55% | 9 | Nov 13, 2024 | |
| PRVA Privia Health Group | Maintains: Buy | $24 → $27 | $22.73 | +18.79% | 6 | Nov 8, 2024 | |
| MEDP Medpace Holdings | Maintains: Hold | $415 → $397 | $347.52 | +14.24% | 2 | Oct 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $7.5 | $6.88 | +9.01% | 15 | Oct 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $15 → $10 | $9.50 | +5.26% | 15 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $13 → $23 | $29.81 | -22.84% | 7 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $14 | $12.71 | +10.15% | 1 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6.4 → $6.5 | $3.41 | +90.62% | 8 | May 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $7.5 → $8 | $4.71 | +69.85% | 11 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $100 | $10.98 | +810.75% | 5 | Sep 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $13 | $9.99 | +30.13% | 11 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $42 → $43 | $14.92 | +188.20% | 6 | Feb 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $30 → $24 | $4.41 | +444.22% | 2 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $14 → $4 | $4.43 | -9.71% | 4 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $58 | $127.83 | -54.63% | 2 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $90 → $45 | $15.06 | +198.80% | 7 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $230 → $333 | $586.08 | -43.18% | 6 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $9 | $4.24 | +112.26% | 2 | May 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $22.09 | - | 3 | Jan 15, 2021 |
Veeva Systems
Jan 13, 2025
Maintains: Hold
Price Target: $261 → $210
Current: $223.04
Upside: -5.85%
Evolent Health
Jan 13, 2025
Maintains: Buy
Price Target: $24 → $20
Current: $10.17
Upside: +96.66%
Astrana Health
Jan 13, 2025
Maintains: Buy
Price Target: $59 → $50
Current: $37.14
Upside: +34.63%
ICON Public Limited Company
Dec 18, 2024
Reiterates: Buy
Price Target: $295 → $284
Current: $205.07
Upside: +38.49%
IQVIA Holdings
Dec 12, 2024
Maintains: Buy
Price Target: $265 → $261
Current: $205.69
Upside: +26.89%
Phreesia
Dec 11, 2024
Maintains: Buy
Price Target: $31 → $34
Current: $27.35
Upside: +24.31%
Doximity
Nov 14, 2024
Maintains: Hold
Price Target: $35 → $49
Current: $55.52
Upside: -11.74%
Progyny
Nov 13, 2024
Downgrades: Hold
Price Target: $26 → $19
Current: $21.48
Upside: -11.55%
Privia Health Group
Nov 8, 2024
Maintains: Buy
Price Target: $24 → $27
Current: $22.73
Upside: +18.79%
Medpace Holdings
Oct 14, 2024
Maintains: Hold
Price Target: $415 → $397
Current: $347.52
Upside: +14.24%
Oct 9, 2024
Maintains: Buy
Price Target: $9 → $7.5
Current: $6.88
Upside: +9.01%
Aug 2, 2024
Maintains: Hold
Price Target: $15 → $10
Current: $9.50
Upside: +5.26%
Jul 18, 2024
Maintains: Hold
Price Target: $13 → $23
Current: $29.81
Upside: -22.84%
Jul 2, 2024
Maintains: Buy
Price Target: $17 → $14
Current: $12.71
Upside: +10.15%
May 24, 2024
Maintains: Hold
Price Target: $6.4 → $6.5
Current: $3.41
Upside: +90.62%
Mar 1, 2024
Maintains: Hold
Price Target: $7.5 → $8
Current: $4.71
Upside: +69.85%
Sep 7, 2022
Initiates: Hold
Price Target: $100
Current: $10.98
Upside: +810.75%
May 4, 2022
Maintains: Neutral
Price Target: $16 → $13
Current: $9.99
Upside: +30.13%
Feb 28, 2022
Maintains: Neutral
Price Target: $42 → $43
Current: $14.92
Upside: +188.20%
Feb 24, 2022
Maintains: Neutral
Price Target: $30 → $24
Current: $4.41
Upside: +444.22%
Feb 8, 2022
Downgrades: Neutral
Price Target: $14 → $4
Current: $4.43
Upside: -9.71%
Feb 4, 2022
Maintains: Neutral
Price Target: $60 → $58
Current: $127.83
Upside: -54.63%
Jan 7, 2022
Downgrades: Underperform
Price Target: $90 → $45
Current: $15.06
Upside: +198.80%
Jan 7, 2022
Upgrades: Outperform
Price Target: $230 → $333
Current: $586.08
Upside: -43.18%
May 19, 2021
Maintains: Neutral
Price Target: $10 → $9
Current: $4.24
Upside: +112.26%
Jan 15, 2021
Downgrades: Underperform
Price Target: n/a
Current: $22.09
Upside: -